Medicare Enrolled

Dr. Kien Tran, MD, PHD

Dermatopathology Physician · Rockwall, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
6800 HERITAGE PKWY, Rockwall, TX 75087
9724755300
In practice since 2007 (18 years)
NPI: 1417158833 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Tran from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tran? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Tran

Dr. Kien Tran is a dermatopathology physician in Rockwall, TX, with 18 years in practice. Based on federal Medicare data, Dr. Tran performed 2,571 Medicare services across 1,251 unique beneficiaries.

Between the years covered by Open Payments, Dr. Tran received a total of $1,676 from 18 pharmaceutical and/or device companies across 68 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatopathology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Tran is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 48% volume in TX$ $1,676 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,571
Medicare services
Top 48% in TX for dermatopathology physician
1,251
Unique beneficiaries
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~143 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Destruction of precancerous skin growths, 2-141,176$5$11
Office visit, established patient (20-29 min)411$58$142
Skin biopsy, tangential221$69$300
Destruction of precancerous skin growth, 1218$35$129
Biopsy of related skin growth, each additional growth147$37$150
Office visit, established patient (30-39 min)147$82$209
Destruction of skin growths (warts/lesions), 1-1497$82$213
New patient office visit (30-44 min)64$77$210
New patient office visit (45-59 min)45$102$320
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm25$115$338
Office visit, established patient (10-19 min)20$38$85
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,676
Total received (2018-2024)
Avg $279/year across 6 years
Top 45% in TX for dermatopathology physician
18
Companies
68
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,502 (89.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$174 (10.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$604
2023
$497
2022
$394
2020
$22
2019
$141
2018
$17

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$207
Amgen Inc.
$167
Lilly USA, LLC
$152
Celgene Corporation
$141
LEO Pharma Inc.
$134
GENZYME CORPORATION
$133
Arcutis Biotherapeutics, Inc.
$126
E.R. Squibb & Sons, L.L.C.
$123
Dermavant Sciences, Inc.
$101
MAYNE PHARMA COMMERCIAL LLC
$67
Novartis Pharmaceuticals Corporation
$67
Regeneron Healthcare Solutions, Inc.
$62
MAYNE PHARMA INC.
$58
ABBVIE INC.
$47
Galderma Laboratories, L.P.
$36
EPI Health, LLC
$22
PFIZER INC.
$17
Almirall LLC
$17
Top 3 companies account for 31.4% of total payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · COSENTYX · DUPIXENT · EUCRISA · HUMIRA · LIBTAYO · Otezla · REMICADE · RINVOQ · Seysara · Sitavig · Sotyktu · TALTZ · TREMFYA · VTAMA · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $65 per 100 Medicare services performed
Looking for a dermatopathology physician in Rockwall?
Compare dermatopathology physicians in the Rockwall area by procedure volume, costs, and industry payment transparency.
Browse dermatopathology physicians nearby

Geographic Context

Dermatopathology Physicians within 10 mi
6
Per 100K population
5.1
County median income
$124,917
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL ROCKWALL
6.4 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Tran is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Tran experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Tran performed 1,176 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tran receive payments from pharmaceutical companies?
Yes. Dr. Tran received a total of $1,676 from 18 companies across 68 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tran's costs compare to other dermatopathology physicians in Rockwall?
Dr. Tran's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tran) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →